IDT is a Registered Research Agency with the Australian Industry Research and Development Board.
This means our clients may be eligible for a 43.5 cents* in the dollar cash rebate or a 38.5%* Tax Shield on eligible R&D activities undertaken by IDT.
With pharmaceutical development projects taking significant time and investment, many IDT clients have used the R&D tax incentive scheme to conduct R&D in a very cost-efficient manner.
A number of our overseas clients have also taken advantage of the R&D Tax Incentive scheme along with the CTN clinical trial notification scheme available in Australia to fast-track their development pathways, whilst claiming a rebate* on their development costs.
*Rebate amounts are subject to change. Contact us at [email protected] to discover more about how your project can benefit from the R&D tax incentive scheme.